Dr. Terashima on Bursectomy for Subserosal and Serosal Gastric Cancer

Video

Masanori Terashima, MD, PhD, FACS, chairman of the Japanese Clinical Oncology Group, discusses bursectomy for patients with subserosal and serosal gastric cancer.

Masanori Terashima, MD, PhD, FACS, chairman of the Japanese Clinical Oncology Group, discusses bursectomy for patients with subserosal and serosal gastric cancer.

In Japan, since the 1950s, bursectomy was standard treatment for patients with advanced gastric cancer. However, due to negative reports, omentectomy became the new standard until a small, randomized phase II study was performed comparing bursectomy with non-bursectomy.

According to the trial, bursectomy seems to improve survival outcomes. However, due to the small sample size, researchers could not detect a significant enough difference between the 2 arms.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD